Bruce Edward Markham
Fondateur chez Phrixus Pharmaceuticals, Inc.
Profil
Bruce Edward Markham is the founder of Phrixus Pharmaceuticals, Inc., which was founded in 2006.
He holds the title of Director & Chief Scientific Officer at Phrixus Pharmaceuticals, Inc. from 2012.
Currently, Dr. Markham is the President, Chief Executive Officer & Director at Diapin Therapeutics LLC.
He was formerly an Associate Professor at The Medical College of Wisconsin, Inc. Dr. Markham obtained a doctorate degree from Michigan State University and an undergraduate degree from Western Michigan University.
Postes actifs de Bruce Edward Markham
| Sociétés | Poste | Début |
|---|---|---|
Phrixus Pharmaceuticals, Inc.
 Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Fondateur | 16/12/2009 |
Diapin Therapeutics LLC
 Diapin Therapeutics LLC BiotechnologyHealth Technology Diapin Therapeutics LLC operates as a pre-seed, preclinical development-staged company .The company was founded by Yuqing Chen in 2011 and is headquartered in Ann Arbor, MI. | Directeur Général | - |
Anciens postes connus de Bruce Edward Markham
| Sociétés | Poste | Fin |
|---|---|---|
| The Medical College of Wisconsin, Inc. | Corporate Officer/Principal | - |
Formation de Bruce Edward Markham
| Western Michigan University | Undergraduate Degree |
| Michigan State University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Phrixus Pharmaceuticals, Inc.
Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
Diapin Therapeutics LLC
Diapin Therapeutics LLC BiotechnologyHealth Technology Diapin Therapeutics LLC operates as a pre-seed, preclinical development-staged company .The company was founded by Yuqing Chen in 2011 and is headquartered in Ann Arbor, MI. | Health Technology |
